Summary
As the pharmacokinetics of a drug may be altered in haemodynamically compromised patients, the plasma concentrations and haemodynamic effects of the calcium entry blocker nimodipine have been examined in patients resuscitated after out-of-hospital cardiac arrest.
In 7 patients nimodipine was infused at increasing rates up to 30 µg·kg−1·h−1. The plasma concentrations increased with increasing dose; at the highest dose a mean steady-state plasma concentration of 22.1 ng·ml−1 was obtained, and the mean plasma clearance was 1.4 l·kg−1·h−1. There were no marked changes in mean arterial blood pressure or heart rate.
In 9 other patients nimodipine was given as a bolus infusion of 10 µg·kg−1 over 3 min, followed by a continuous infusion of 30 µg·kg−1·h−1. A mean steady-state plasma concentration of 17.6 ng·ml−1 was obtained and the mean plasma clearance was 1.9 l·kg−1·h−1. Heart rate did not change significantly, but the mean arterial blood pressure fell.
The data indicate that in patients resuscitated after cardiac arrest, the pharmacokinetics of nimodipine are not markedly different from patients with other conditions, e.g. subarachnoid haemorrhage. However, if a loading dose is given to obtain a steady-state concentration sooner, there will be a fall in arterial blood pressure.
Similar content being viewed by others
References
Kazda S, Garthoff B, Krause HP, Schlossman K (1982) Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments. Arzneimittelforsch 32: 331–338
Steen PA, Gisvold SE, Milde JH, Newberg LA, Scheithauer BW, Lanier WL, Michenfelder ID (1985) Nimodipine improves outcome when given after complete cerebral ischemia in primates. Anesthesiology 62: 406–414
Dearden NM (1985) Ischaemic brain. Lancet 2: 255–259
Roine RO, Kaste M, Kinnunen A, Nikki P (1987) Safety and efficacy of nimodipine in resuscitation of patients outside hospital. Br Med J 294: 20
Satoh K, Kawada M, Wada Y, Taira N (1984) Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog. Arzneimittelforsch 34: 563–568
Huyghens LP, Rosseel MT, Calle PA, Buylaert WA (1987) Influence of cardiopulmonary resuscitation on plasma concentrations of nimodipine in the dog. J Pharm Pharmacol 39: 991–996
Pentel P, Benowitz M (1984) Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies. Clin Pharmacokinet 9: 273–308
Raemsch KD, Ahr G, Tettenborn D, Auer CM (1985) Overview of pharmacokinetics of nimodipine in healthy volunteers and in patients with subarachnoid hemorrhage. Neurochirurgia 28: 74–78
Auer LM (1983) Acute surgery of cerebral aneurysms and prevention of symptomatic vasospasm. Acta Neurochir 59: 273–281
Vinge E, Andersson KE, Brandt L, Ljunggren B, Nilsson LG, Rosendal-Helgesen S (1986) Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid haemorrhage. Eur J Clin Pharmacol 30: 421–425
Rosseel MT, Bogaert MG (1989) Determination of the calcium antagonist nimodipine in plasma by capillary gas chromatography and nitrogen detection. J Pharmacol Biomed Anal (in press)
Tettenborn D, Dycka J, Volberg E, Dudden P (1985) Blood pressure and heart rate during treatment with nimodipine in patients with subarachnoid hemorrhage. Neurochirurgia 28: 84–86
v. Bormann BU, Boldt J, Kling D, Mulch J, Weidler B, Hempelmann G (1985) Influence of nimodipine on cardiovascular parameters during coronary surgery. Neurochirurgia 28: 79–83
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Huyghens, L.P., Buylaert, W.A., Corne, L. et al. Plasma concentrations and haemodynamic effects of nimodipine in patients resuscitated after cardiac arrest. Eur J Clin Pharmacol 36, 327–333 (1989). https://doi.org/10.1007/BF00558290
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558290